908 Devices Inc.
HealthcareNASDAQ:MASS · NASDAQ Global Market
+$0.05 today
Vol 0.15M · Avg 0.27M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-25.5%
avg -13.9%
ROIC
-14.0%
avg -23.3%
ROA
-19.3%
avg -21.8%
Analysis
ROIC is currently the strongest return metric at -14.0% versus its period average of -23.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Kevin J. Knopp | Co-Founder, Chief Executive Officer, President & Director | $1.03M | — | 53 | $13,656.00 | 0.04% |
Joseph H. Griffith | Chief Financial Officer & Treasurer | $796,756.00 | — | 51 | $132,956.00 | 0.35% |
John Kenneweg | Senior Vice President of Sales and Product Marketing | $783,621.00 | — | 53 | $57,784.00 | 0.15% |
Christopher David Brown | Co-Founder, Board Advisor & Director | $555,607.00 | — | 51 | $875,459.00 | 2.32% |
Mark S. Levine | Chief Legal, Administrative Officer & Corporate Secretary | $21,635.00 | — | 53 | $13,656.00 | 0.04% |
Kevin McCallion | Senior Vice President of Products and Production | — | — | 60 | $13,656.00 | 0.04% |
Don Osmer | Vice President of Human Resources | — | — | 60 | — | — |
Kola Otitoju | Chief Business & Strategy Officer | — | — | 53 | $146,789.00 | 0.39% |
Barbara Russo | Vice President of Corporate Marketing and Communications | — | — | 62 | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
33
$4.61M
Net Sentiment
$4.61M
Net selling
Most Active
AWM Investment Company, Inc.
10 transactions
1–10 of 33
Analysis
Insiders reported 0 buys worth $0.00 and 33 sells worth $4.61M over the last 12 months. That adds up to net selling of $4.61M. AWM Investment Company, Inc. was the most active insider with 10 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +37.6% | +11.7% (7yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +37.6% over three years. Forward estimates point to Revenue at +11.7% (7yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$1.18B
NeuroPace, Inc.
NASDAQ:NPCE
$533.23M
Aclaris Therapeutics, Inc.
NASDAQ:ACRS
$520.97M
Cerus Corporation
NASDAQ:CERS
$512.94M
Senseonics Holdings, Inc.
NASDAQ:SENS
$299.93M
Sight Sciences, Inc.
NASDAQ:SGHT
$279.12M
Quanterix Corporation
NASDAQ:QTRX
$146.03M
CVRx, Inc.
NASDAQ:CVRX
$133.48M
SANUWAVE Health, Inc.
NASDAQ:SNWV
$128.21M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$122.48M
Who manages MASS?
908 Devices Inc. (MASS) lists 9 active executives. The top listed executive is Kevin McCallion, Senior Vice President of Products and Production.
Are MASS insiders buying or selling?
Recent insider activity shows net selling of $1.44M.
Explore More
Continue the stock analysis
Jump to another research area for this company.